Results 131 to 140 of about 22,385,248 (304)
A high performance computing technology powered multimedia fusion model in university English translation. [PDF]
Shi L, DuJiang M, Gao P.
europepmc +1 more source
In this explorative study, the abundance of circular RNA molecules in bone marrow stem cells was found to be elevated in patients with high‐risk myelodysplastic neoplasms, and to be associated with an increased risk of progression to acute myeloid leukemia.
Eileen Wedge +17 more
wiley +1 more source
Review: understanding the properties of amorphous materials with high-performance computing methods. [PDF]
Christie JK.
europepmc +1 more source
Cytarabine is a key therapy for acute myeloid leukaemia (AML), but its efficacy is limited by the dNTPase SAMHD1, which hydrolyses its active metabolite. Screening nucleotide biosynthesis inhibitors revealed that IMPDH inhibitors selectively sensitise SAMHD1‐proficient AML cells to cytarabine.
Miriam Yagüe‐Capilla +9 more
wiley +1 more source
.Net High Performance Computing based on Windows HPC Server 2008 R2
High performance computing is not one of the original goals for Microsoft .NET programmers, but it did bring development benefit to developers via providing a complete and robust environment for development.
Aykut, Erkin
core
Retracted: Digital Protection and Development of Intangible Cultural Heritage Relying on High-Performance Computing. [PDF]
Intelligence And Neuroscience C.
europepmc +1 more source
In the present work, we have identified a transcriptional signature based on the differential expression of six genes (BCL2&MAST4, HSH2D&LAT2, METRN&PITPNM2) that would facilitate the early detection of T‐cell acute lymphoblastic leukemia (T‐ALL) patients prone to a poor treatment response and could be implemented at diagnosis, along with other risk ...
Antonio Lahera +11 more
wiley +1 more source
Teaching computational genomics and bioinformatics on a high performance computing cluster-a primer. [PDF]
Sethuraman A.
europepmc +1 more source
KDM7A and KDM1A inhibition suppresses tumour promoting pathways in prostate cancer
Treatment resistance is a major challenge for patients with advanced prostate cancer. This study examined an alternative approach to target the major prostate cancer‐promoting pathway by targeting epigenetic factors, whose levels are higher in tumours.
Jennie N Jeyapalan +16 more
wiley +1 more source

